ECS Stock Overview
Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
ECS Botanics Holdings Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.017 |
52 Week High | AU$0.029 |
52 Week Low | AU$0.013 |
Beta | 1.28 |
11 Month Change | -5.56% |
3 Month Change | 13.33% |
1 Year Change | -29.17% |
33 Year Change | -43.33% |
5 Year Change | -61.36% |
Change since IPO | -73.85% |
Recent News & Updates
Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop
Nov 11There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise
Sep 27Recent updates
Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop
Nov 11There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise
Sep 27ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business
Aug 12There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding
Apr 03ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk
Sep 06ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans
Feb 24Shareholder Returns
ECS | AU Pharmaceuticals | AU Market | |
---|---|---|---|
7D | 0% | -11.8% | 1.5% |
1Y | -29.2% | 39.8% | 17.2% |
Return vs Industry: ECS underperformed the Australian Pharmaceuticals industry which returned 39.8% over the past year.
Return vs Market: ECS underperformed the Australian Market which returned 17.2% over the past year.
Price Volatility
ECS volatility | |
---|---|
ECS Average Weekly Movement | 15.2% |
Pharmaceuticals Industry Average Movement | 11.9% |
Market Average Movement | 8.6% |
10% most volatile stocks in AU Market | 17.3% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: ECS's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: ECS's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Nan-Maree Schoerie | www.ecs-botanics.com |
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. The company is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.
ECS Botanics Holdings Ltd Fundamentals Summary
ECS fundamental statistics | |
---|---|
Market cap | AU$21.91m |
Earnings (TTM) | AU$1.92m |
Revenue (TTM) | AU$20.03m |
11.4x
P/E Ratio1.1x
P/S RatioIs ECS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ECS income statement (TTM) | |
---|---|
Revenue | AU$20.03m |
Cost of Revenue | AU$12.52m |
Gross Profit | AU$7.51m |
Other Expenses | AU$5.60m |
Earnings | AU$1.92m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0015 |
Gross Margin | 37.51% |
Net Profit Margin | 9.56% |
Debt/Equity Ratio | 0% |
How did ECS perform over the long term?
See historical performance and comparison